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The saposins are essential cofactors for the normal lysosomal degradation of
complex glycosphingolipids by acid hydrolase enzymes; defects in either saposin
or hydrolase function lead to severe metabolic diseases. Saposin A (SapA)
activates the enzyme -galactocerebrosidase (GALC), which catalyzes the
breakdown of -d-galactocerebroside, the principal lipid component of myelin.
SapA is known to bind lipids and detergents in a pH-dependent manner; this is
accompanied by a striking transition from a ‘closed’ to an ‘open’ conformation.
However, previous structures were determined at non-lysosomal pH. This work
describes a 1.8 A˚ resolution X-ray crystal structure determined at the
physiologically relevant lysosomal pH 4.8. In the absence of lipid or detergent
at pH 4.8, SapA is observeed to adopt a conformation closely resembling the
previously determined ‘closed’ conformation, showing that pH alone is not
sufficient for the transition to the ‘open’ conformation. Structural alignments
reveal small conformational changes, highlighting regions of flexibility.
1. Introduction
The lysosomal breakdown of complex glycosphingolipids
(GSLs) is essential for normal cellular homeostasis and recy-
cling of essential macromolecular building blocks. GSL
substrates for degradation are embedded in membranes of
lysosomal intralumenal vesicles, where complex glycan head
groups are disassembled one residue at a time by the
sequential action of lysosomal acid hydrolase enzymes
(Sandhoff & Kolter, 1996; Kolter & Sandhoff, 2005, 2010).
The active sites of these enzymes are typically shallow; in a
membrane environment the steric crowding of head groups
and lateral association of GSLs into clusters prevents enzymes
from accessing the scissile bonds of their target substrates.
Saposins A, B, C and D comprise a family of small, non-
enzymatic lipid-transfer proteins that are essential for the
activation of GSL catabolism; genetic defects in saposin
function cause specific forms of lysosomal storage diseases
(Spiegel et al., 2005; Sun et al., 2010; Sun & Grabowski, 2013).
The four saposins are derived from proteolytic cleavage of
prosaposin, which is expressed as a single gene product
(Hiraiwa et al., 1997). Each saposin shows functional specifi-
city for the activation of certain catabolic reactions: saposin A
(SapA) activates the hydrolysis of -d-galactocerebroside to
ceramide and galactose by the enzyme -galactocerebrosidase
(GALC; EC 3.2.1.46; Morimoto et al., 1989; Harzer et al.,
1997).
The structures of all four saposins have previously been
determined by X-ray crystallography (Ahn, Faull, Whitelegge,
ISSN 2053-230X
Fluharty et al., 2003; Ahn et al., 2006; Rossmann et al., 2008;
Popovic & Prive´, 2008) or NMR spectroscopy (de Alba et al.,
2003). Whilst they share less than 35% sequence identity, they
all adopt a common fold consisting of four amphipathic
-helices organized into two ‘fingers’. This fold forms the basis
of a large, diverse superfamily of lipid-binding saposin-like
proteins (SAPLIPs), members of which are found amongst
phylogenetically distant eukaryotes, including metazoa, plants
and mammals (Bruhn, 2005).
Previous structural work has described SapA in a mono-
meric ‘closed’ conformation in the absence of lipid (Ahn et al.,
2006) and more recently a homodimeric ‘open’ conformation
in lipoprotein discs formed by the presence of the detergent
lauryldimethylamine oxide (LDAO; Popovic et al., 2012).
These structures were determined at pH 6.0 and 6.5, respec-
tively. However, SapA dimerization, lipid binding and
membrane excavation only occurs at acidic pH (Vaccaro et al.,
1995; Ahn et al., 2006; Locatelli-Hoops et al., 2006) and it is
unclear what role pH plays in the transition between the
‘closed’ and ‘open’ conformations. The aim of this study was to
determine the structure of SapA at a lysosomal pH, thus
generating an additional snapshot of the protein at a pH
where it is functionally active, providing insights into pH-
dependent conformational changes.
2. Materials and methods
2.1. Cloning, protein expression and purification
A codon-optimized, untagged cDNA encoding human
SapA was synthesized by GeneArt and cloned into expression
vector pET-15b using NcoI and XhoI restriction-endonuclease
sites. The resultant construct was checked by sequencing with
the T7F primer (50-TAATACGACTCACTATAGGG-30). The
amino-acid sequence of this construct (MGSLPCDICKDV-
VTAAGDMLKDNATEEEILVYLEKTCDWLPKPNMSAS-
CKEIVDSYLPVILDIIKGEMSRPGEVCSALNLCESLQ) is
equivalent to residues 60–142 of the precursor prosaposin
(UniProt entry P07602), with an additional Met-Gly at the
N-terminus as a result of the cloning strategy.
The protein was expressed in Escherichia coli Origami
(DE3) cells and cultures (1 l) were grown in 2TY medium
supplemented with 50 mg ml1 ampicillin and 12.5 mg ml1
tetracycline (37C with shaking at 230 rev min1). Expression
was induced for 4 h at 37C by the addition of 1.0 mM
isopropyl -d-1-thiogalactopyranoside (IPTG) when the
culture reached an optical density at 600 nm of 0.6. The cells
were harvested by centrifugation (5000g, 20 min) and
washed with phosphate-buffered saline prior to storage at
20C.
research communications
896 Hill et al.  Human saposin A Acta Cryst. (2015). F71, 895–900
Figure 1
Human SapA crystallization and mounting. (a) SapA crystalline needle cluster grown by sitting-drop vapour diffusion against a reservoir consisting of
0.1 M sodium acetate pH 4.8, 0.2 M lithium sulfate, 25%(w/v) PEG 4000. A single needle (10  150 mm) is shown mounted in a nylon loop. (b) Details of
crystal packing, showing views of the unit cell along the b (left) and a (right) axes. Two protein molecules are present per asymmetric unit (grey). The
crystals contain 33.2% solvent, with a Matthews coefficient of 1.84 A˚3 Da1.
The presence of three disulfide bonds per saposin molecule
confers remarkable thermal stability, which has previously
been exploited for protein purification without affinity tags
(Ahn, Faull, Whitelegge, Higginson et al., 2003; Ahn et al.,
2006). Bacterial pellets from 1 l culture were thawed and
resuspended in 30 ml ice-cold anion-exchange (AEX) buffer
(50 mM Tris pH 7.4, 25 mM NaCl). This was passed twice
through a hydraulic cell disruptor (Constant Systems TS) at
206 MPa pressure and 8C. Insoluble cell-wall and membrane
fractions were pelleted by centrifugation (40 000g, 40 min,
4C) and discarded. The cleared lysate was then heat-treated
in a water bath (100C, 30 min). Denatured, precipitated
E. coli native proteins were then pelleted by centrifugation
(40 000g, 40 min, 4C) and discarded. The supernatant was
then supplemented with 20 mg ml1 DNase I, 2.5 mM MgCl2,
0.5 mM CaCl2 and incubated with gentle mixing (room
temperature, 4 h). This crude 50 ml extract was then dialyzed
overnight (3500 MWCO, Thermo Scientific) against 5 l AEX
buffer.
A 5.0 ml HiTrap QSepharose column (GE) was equilibrated
with 10 column volumes (CV) of AEX buffer before loading
the crude SapA extract using a peristaltic pump at
5.0 ml min1. The column was then washed with 10 CV AEX
buffer and connected to an FPLC (A¨KTApurifier, GE) for
elution of bound proteins with a 0–50% gradient of 50 mM
Tris pH 7.4, 1 M NaCl over 20 CV. All fractions containing
saposins were pooled and concentrated to a volume of 5.0 ml
using Vivaspin 20 centrifugal concentrators (3000 MWCO,
GE). A HiLoad 16/600 Superdex 75 column (GE) connected
to the FPLC was equilibrated with 1.5 CV size-exclusion
(SEC) buffer (50 mM Tris pH 7.4, 150 mM NaCl) prior to the
injection of 5.0 ml of the concentrated AEX elution. Isocratic
elution with SEC buffer was performed at 1.0 ml min1 over
1.2 CV. Fractions corresponding to the main A280 peak were
pooled and stored at 4C. Purified SapA was stable for at least
six months.
2.2. Crystallization
Human SapA was concentrated to 19.6 mg ml1 in 150 mM
NaCl, 50 mM Tris pH 7.4 using Amicon Ultra 3.5 kDa
molecular-mass centrifugal concentrators (Millipore). Crys-
tallization experiments were set up in 96-well sitting-drop
vapour-diffusion plates using an Innovadyne Screenmaker
96+8 Xtal microfluidic handling platform. Diffraction-quality
crystals were grown in 400 nl drops (200 nl protein and 200 nl
reservoir solution) at 293 K by equilibration against an 80 ml
reservoir consisting of 0.2 M lithium sulfate, 0.1 M sodium
acetate pH 4.8, 25%(w/v) polyethylene glycol 4000. The final
pH of the crystallization drop was verified experimentally as
pH 4.8. Crystals grew as clusters of needles and were dissected
with an acupuncture needle before mounting to obtain single
crystals (Fig. 1a), which were cryoprotected with 20%(v/v)
glycerol and flash-cooled in liquid nitrogen.
2.3. Data collection and processing
Data-collection and processing statistics are detailed in
Table 1. Crystals were maintained at a temperature of 100 K
during data collection. Diffraction data were recorded on
beamline I03 at Diamond Light Source using a Pilatus 6M
detector (Dectris). Data sets of 1800 images were collected at
 = 0.9763 A˚ over a 360 oscillation range with ’ = 0.2, t =
0.2 s, transmission = 18.05% (3.07  1011 photons s1).
Diffraction data were processed using the xia2 pipeline
(Winter, 2010) implementing XDS (Kabsch, 2010) for data
indexing and integration, POINTLESS (Evans, 2006) for
point-group determination and SCALA (Evans, 2006) for
scaling and merging. The resolution cutoff was decided by
CC1/2 > 0.5 in the outer resolution shell (Karplus & Diederichs,
2012).
2.4. Structure solution, refinement and analysis
The structure was solved by molecular replacement with
Phaser (McCoy et al., 2007), using the known structure of
human SapA at pH 6.0 (PDB entry 2dob; Ahn et al., 2006) as a
search model. All further model adjustment and refinement
was performed iteratively using Coot (Emsley et al., 2010) and
phenix.refine (Afonine et al., 2012) (Table 2). H atoms were
refined in the riding position. Validation tests implemented in
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Table 1
Data collection and processing.
Values in parentheses are for the outer shell.
Space group P21
a, b, c (A˚) 34.17, 58.69, 35.16
, ,  () 90.0, 93.1, 90.0
Mosaic spread () 0.146
Resolution range (A˚) 34.12–1.80 (1.86–1.80)
Completeness (%) 98.6 (97.7)
Multiplicity 6.8 (6.8)
hI/(I)i† 11.2 (1.8)
CC1/2‡ 0.997 (0.676)
Rmeas 0.122 (1.182)
Overall B factor from Wilson plot (A˚2) 22.72
† Mean I/(I) is >2.0 at resolutions of >1.9 A˚. ‡ The CC1/2 values were used to decide
the resolution cutoff (Karplus & Diederichs, 2012).
Table 2
Structure solution and refinement.
Values in parentheses are for the outer shell.
Resolution range (A˚) 34.12–1.80 (1.86–1.80)
No. of reflections, working set 12126 (1179)
No. of reflections, test set 612 (64)
Final Rwork 0.186
Final Rfree 0.210
No. of non-H atoms
Protein 1304
Water 26
Total 1330
R.m.s. deviations
Bonds (A˚) 0.004
Angles () 0.807
Average B factors (A˚2)
Protein 25.4
Water 31.6
Ramachandran plot
Most favoured (%) 98.8
Allowed (%) 1.2
Outliers (%) 0
MolProbity (Chen et al., 2010) were consulted throughout the
refinement process. For the electrostatic potential calculations,
partial charges were assigned using the PDB2PQR server
(Dolinsky et al., 2004), implementing PROPKA (Li et al.,
2005) to estimate side-chain pKa values. Electrostatic surfaces
were calculated using APBS (Baker et al., 2001) and structural
figures were rendered using PyMOL (Schro¨dinger).
Sequence-alignment graphics were prepared using ALINE
(Bond & Schu¨ttelkopf, 2009). The atomic coordinates and
structure factors have been deposited in the PDB under
accession code 4uex.
3. Results and discussion
3.1. SapA remains in the ‘closed’ conformation at lysosomal
pH 4.8
Human SapA crystals belong to the monoclinic space group
P21 and have a relatively low solvent content of 33.2% as
estimated by the Matthews method (Matthews, 1968; VM =
1.84 A˚3 Da1; Fig. 1b). The asymmetric unit contains two
molecules of SapA, both in the closed conformation, with the
characteristic saposin fold (Ahn, Faull, Whitelegge, Fluharty
et al., 2003; Ahn et al., 2006). Each monomer consists of two
‘fingers’ composed of an 1–4 stem and an 2–3 hairpin
(Fig. 2a). These motifs are secured by three intramolecular
disulfide bridges connecting the terminal helices 1 and 4
and the central helices 2 and 3. Helix 3 is kinked at the
conserved residue Tyr54. The helices are amphipathic and are
oriented such that hydrophobic lipid-binding side chains are
buried in the centre of the ‘closed’ conformation. Acidic
residues comprise the solvent-accessible outer surface,
creating an estimated electrostatic surface potential of 8.0 e
at lysosomal pH 4.8, although small basic and neutral patches
remain (Fig. 2b). As the theoretical isoelectric point of SapA is
4.2, the charge distribution seen here is not significantly
different from that at pH 6.0–7.4. Two flexible coil regions act
as hinges, allowing movement of the ‘fingers’ relative to one
another to accommodate lipid or detergent molecules, as
previously shown for saposins A, B and C (Ahn, Faull,
Whitelegge, Fluharty et al., 2003; Hawkins et al., 2005; Ahn et
al., 2006; Popovic et al., 2012). In the case of SapA, upon
transition to the open conformation, the 3 helix is extended
by the coil residues 63–67 and the kink at Tyr54 is preserved.
3.2. Crystal packing is pseudosymmetric
In this structure, two molecules were observed in the
asymmetric unit. The two molecules are related by an
approximate 21 screw axis parallel to the c cell edge. With the
unit-cell  angle of 93.1, the overall symmetry deviates
substantially from space group P212121. Analysis with PDBe-
PISA (Krissinel & Henrick, 2007) suggests that the two
molecules in the asymmetric unit form a crystallographic
pseudodimer and not a stable quaternary complex. This is
consistent with observations that SapA remains monomeric at
low pH in the absence of detergent (Ahn et al., 2006).
3.3. Structural alignment reveals regions of flexibility
The two chains observed in the asymmetric unit are almost
identical, with a backbone r.m.s.d. of 0.46 A˚ after least-squares
alignment. Inspection of side-chain dihedral angles revealed
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Figure 2
X-ray crystal structure of SapA at lysosomal pH. (a) Monomeric SapA is shown in three orientations. Disulfide bonds are shown as yellow spheres. (b)
The molecular surface is shown coloured by electrostatic potential at the solvent-accessible surface from red (negative, 3.0 kT e1) to blue (positive,
+3.0 kT e1). Electrostatic potential was calculated using a pH value of 4.8 when assigning side-chain protonation.
small conformational changes in a few residues as a result of
crystal packing, including Lys19, Glu24, Glu25, Lys33, Ser46,
Ile50 and Glu65. The largest difference was seen at Trp37,
which was observed in a dual-occupancy conformation in
chain B only, indicating that this side chain is mobile. Align-
ment of both chains in this structure with the SapA structure
at pH 6.0 (Ahn et al., 2006; PDB entry 2dob) reveals additional
conformational changes, with backbone r.m.s.d. values of
0.94 A˚ for both chains after least-squares fit alignment
(Fig. 3a). The largest differences are observed at the
ends of helices and in the flexible hinge regions; residues
19–21 between 1 and 2 and residues 62–67 between 3 and
4.
Interestingly, several residues on the solvent-accessible face
of helix 2 are observed in different conformations in all three
chains, indicating these side chains to be highly mobile. In vitro
studies of the interaction of SapA with phosphatidylserine
(PS) liposomes using tryptophan fluorescence spectroscopy
and quenching experiments showed that the Trp37 side chain
can associate with lipids and is thought to insert into
membranes by about five carbon-bond lengths (Qi &
Grabowski, 2001). Similarly, measurements of tryptophan
fluorescence within SapA lipoprotein discs show this residue
to be lipid-associated, regardless of lipid composition (Popovic
et al., 2012). The conformational flexibility observed in this
region could facilitate the association of closed, monomeric
SapA with membranes prior to lipid binding and lipoprotein
disc formation via membrane insertion of the bulky hydro-
phobic residues Tyr30 and Trp37. Residue Tyr30 is very well
conserved amongst vertebrate SapA orthologues, and Trp37,
although not fully conserved, is substituted by other hydro-
phobic residues (phenylalanine or leucine), supporting an
important functional role for these residues. Interestingly,
Tyr30 and Trp37 are not conserved across the different saposin
molecules, suggesting that the role of these residues in lipid
interactions differs between saposins.
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Figure 3
Alignment of monomeric, closed SapA structures. (a) Sequence diagram of human SapA. The highlighted features are cysteines that form disulfide
bonds (yellow circles) and asparagines where N-linked glycosylation occurs (pink diamonds). The bar graphs beneath the sequence show the backbone
r.m.s.d. per residue after least-squares fit alignment of PDB entry 2dob with chain A, of PDB entry 2dob with chain B and of chain A with chain B. Dark
grey bars indicate r.m.s.d > 1.0 A˚. (b) Least-squares fit alignment of the human SapA structure determined here (chain A, purple; chain B, teal) with the
previous structure at pH 6.0 (PDB entry 2dob, grey). Ribbon thickness in nonhelical regions is proportional to atomic B factor. Details of the greatest
conformational differences are shown as sticks, including flexible hinge coil regions (indicated) and the outer surface of the 2 helix.
In contrast, helices 1, 3 and 4 have low backbone
r.m.s.d. values and mostly identical side-chain conformations
(Fig. 3b). Comparison of atomic B factors shows that the 3–
4 hinge region is more ordered in both chains of the pH 4.8
structure than in the pH 6.0 structure. However, owing to the
low solvent content and pseudosymmetry observed in these
crystals, it is difficult to determine whether the differences
observed here are a result of pH alone or are influenced by
crystal packing.
4. Conclusions
There are no large-scale conformational rearrangements
accompanying pH change, emphasizing the absolute necessity
of lipids or detergents for transition to the open conformation
(Ahn et al., 2006; Popovic et al., 2012). However, in combi-
nation with the structure of closed SapA at pH 6.0, this work
reveals regions of conformational flexibility, and the crystal
packing suggests a tendency to bury the negatively charged 3
helix at lysosomal pH. This may have implications for a direct
interaction with the hydrolase enzyme GALC, which has a
positive surface charge surrounding the active site at lyso-
somal pH (Deane et al., 2011; Hill et al., 2013).
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